Published in Br Med J (Clin Res Ed) on December 17, 1983
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ (1994) 11.85
The tribulations of trials--intervention in communities. Am J Public Health (1995) 5.38
Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health (1994) 4.79
Mass media and smoking cessation: a critical review. Am J Public Health (1987) 3.94
Dietary reduction of serum cholesterol concentration: time to think again. BMJ (1991) 3.10
Reducing alcohol-impaired driving in Massachusetts: the Saving Lives Program. Am J Public Health (1996) 2.63
Community intervention trial for smoking cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. Am J Public Health (1995) 2.38
Preliminary trial of the effect of general practice based nutritional advice. Br J Gen Pract (1990) 2.02
What is the "golden standard" for assessing population-based interventions?--problems of dilution bias. J Epidemiol Community Health (2000) 1.69
Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ (2004) 1.51
A television format for national health promotion: Finland's "Keys to Health". Public Health Rep (1987) 1.37
Changes in adult cigarette smoking in the Minnesota Heart Health Program. Am J Public Health (1995) 1.29
Use of lay opinion leaders to promote diffusion of health innovations in a community programme: lessons learned from the North Karelia project. Bull World Health Organ (1986) 1.23
Scottish hearts but British habits. BMJ (1989) 1.15
The National Health Service: doctors and society beyond 2000. J R Soc Med (1999) 1.14
The importance of diet and physical activity in the treatment of conditions managed in general practice. Br J Gen Pract (1996) 1.05
Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. J Epidemiol Community Health (1991) 1.03
Smoking and leanness: evidence for change in Finland. BMJ (1989) 0.98
Changes in perceived heart disease risk and health during a community-based heart disease prevention program: the North Karelia project. Am J Public Health (1984) 0.98
Costs of the 'Hartslag Limburg' community heart health intervention. BMC Public Health (2006) 0.96
Primary prevention trials in cardiovascular disease. J Epidemiol Community Health (1990) 0.95
Coffee consumption is correlated with serum cholesterol in middle-aged Finnish men and women. J Epidemiol Community Health (1987) 0.94
The Washington Heights-Inwood Healthy Heart Program: a 6-year report from a disadvantaged urban setting. Am J Public Health (1996) 0.93
Rationale and design of the Primary pREvention strategies at the community level to Promote Adherence of treatments to pREvent cardiovascular diseases trial number (CTRI/2012/09/002981). Am Heart J (2013) 0.93
Prevalence, Awareness, Treatment, and Control of High Blood Pressure: A Population-Based Survey in Thai Nguyen, Vietnam. PLoS One (2013) 0.92
Effectiveness of treatment with antihypertensive drugs and trends in mortality from stroke in the community. Br Med J (Clin Res Ed) (1985) 0.92
Hypertension in women: a separate case for treatment? Br Med J (Clin Res Ed) (1984) 0.84
The challenge of preventing cardiovascular disease in Tunisia. Prev Chronic Dis (2005) 0.84
Increasing physical activity of high intensity to reduce the prevalence of chronic diseases and improve public health. Open Cardiovasc Med J (2013) 0.83
An integrated approach to preventing cardiovascular disease: community-based approaches, health system initiatives, and public health policy. Risk Manag Healthc Policy (2010) 0.83
School-based Intervention to Promote Healthy Lifestyles in Sousse, Tunisia. Indian J Community Med (2010) 0.80
Effects of legislative reform to reduce drunken driving and alcohol-related traffic fatalities. Public Health Rep (1988) 0.80
Contribution of education level and dairy fat sources to serum cholesterol in Russian and Finnish Karelia: results from four cross-sectional risk factor surveys in 1992-2007. BMC Public Health (2012) 0.78
The impact of a cardiovascular health awareness program (CHAP) on reducing blood pressure: a prospective cohort study. BMC Public Health (2013) 0.77
Changes in incidence and prognosis of ischaemic heart disease in Finland: a record linkage study of data on death certificates and hospital records for 1972 and 1981. Br Med J (Clin Res Ed) (1985) 0.77
Report of the New England Task Force on Reducing Heart Disease and Stroke Risk. Public Health Rep (1989) 0.75
Effects of legal penalty changes and laws to increase drunken driving convictions on fatal traffic crashes. Bull N Y Acad Med (1989) 0.75
Primordial and primary prevention programs for cardiovascular diseases: from risk assessment through risk communication to risk reduction. A review of the literature. Clinics (Sao Paulo) (2016) 0.75
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet (1981) 7.05
UK heart disease prevention project: incidence and mortality results. Lancet (1983) 4.19
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75
The community-based model of life style intervention trials. Am J Epidemiol (1978) 3.12
Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95
Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80
Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72
The North Karelia project: an attempt at community prevention of cardiovascular disease. WHO Chron (1973) 2.53
Belgian heart disease prevention project: incidence and mortality results. Lancet (1983) 2.23
Incidence and presentation of myocardial infarction in North Karelia, Finland. Acta Med Scand (1975) 1.84
Trends of mortality from ischaemic heart disease and other cardiovascular diseases in 27 countries, 1968-1977. World Health Stat Q (1982) 1.72
Coronary risk factors and socioeconomic status in Eastern Finland. Prev Med (1978) 1.39
The levels of the major risk indicators of cardiovascular diseases in Eastern Finland rior to a community-based intervention programme. (The North Karelia project). Acta Cardiol (1979) 1.02
DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet (1998) 11.70
Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27
Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation (1992) 7.11
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20
Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16
Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02
Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med (1997) 5.79
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health (2002) 5.48
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet (1983) 5.31
Early growth and coronary heart disease in later life: longitudinal study. BMJ (2001) 5.25
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25
Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ (1999) 5.17
Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia (1999) 5.11
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care (2000) 4.62
Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42
Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet (2001) 4.39
The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30
The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med (2000) 4.29
Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
The genetically isolated populations of Finland and sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet (2000) 3.92
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ (1994) 3.92
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol (2000) 3.78
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75
Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ (1997) 3.63
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56
A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia (1993) 3.35
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10
Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05
Symptoms of chronic bronchitis and the risk of coronary disease. Lancet (1996) 3.03
Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control (1996) 3.01
Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation (1995) 2.99
Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95
Socioeconomic conditions in childhood and ischaemic heart disease during middle age. BMJ (1990) 2.91
Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91
Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ (1995) 2.89
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83
Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80
Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80
Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ (1999) 2.78
Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation (1999) 2.78
Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor study. Int J Epidemiol (1996) 2.73
Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
Community-based noncommunicable disease interventions: lessons from developed countries for developing ones. Bull World Health Organ (2001) 2.68
Asthma programme in Finland: a community problem needs community solutions. Thorax (2001) 2.68
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet (2002) 2.65
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet (2000) 2.62
Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life. Diabetologia (2003) 2.60
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59
Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet (1978) 2.56
The North Karelia project: an attempt at community prevention of cardiovascular disease. WHO Chron (1973) 2.53
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia (1999) 2.51